Bacigalupa, Zachary A.
Rathmell, W. Kimryn http://orcid.org/0000-0002-4984-0225
Article History
First Online: 11 November 2021
Competing interests
: W.K.R. declares research support from Incyte and support to an immediate family member as a founder, scientific advisory board member and stockholder of Sitryx Therapeutics; is a scientific advisory board member and stockholder of Caribou Biosciences; is a member of the scientific advisory board of Nirogy Therapeutics; and is a consultant for Merck, Pfizer, Mitobridge, Calithera Biosciences and Tempest Therapeutics. Z.A.B. declares no competing interests.